In Vitro Phenotypic Alteration of Human Melanoma Cells Induced by Differentiating Agents: Heterogeneous Effects on Cellular Growth and Morphology, Enzymatic Activity, and Antigenic Expression
- 1 November 1990
- journal article
- research article
- Published by Wiley in Pigment Cell Research
- Vol. 3 (5) , 223-232
- https://doi.org/10.1111/j.1600-0749.1990.tb00294.x
Abstract
Sodium butyrate (butyrate), 5-azacytidine (5Aza-C), dimethyl sulfoxide (DMSO), and dimethyl formamide (DMF) were applied to a human melanoma cell line for the purpose of inducing pigmentation and terminal differentiation. The results are summarized as follows: 1) butyrate, DMSO, and DMF had a strong cytostatic effect, arresting cells in the G1 phase of the cycle; 2) butyrate caused a morphological change to spindle shape whereas DMSO and DMF produced rounded cells, without affecting the levels of vimentin and intermediate filaments; 3) tyrosinase activity and melanization were stimulated by DMSO and DMF but not by butyrate; 4) butyrate induced several membrane-bound enzyme activities (alkaline phosphatase and gamma-glutamyl transpeptidase); 5) changes in the expression of antigens related to tyrosinase activity (2B7 and 5C12) only partly corresponded to the changes in enzyme activity; 6) expression of the melanosomal B8G3 antigen was decreased by butyrate, DMSO, and DMF; and 7) the action of DMF resembled that of DMSO whereas 5Aza-C had little effect. The results indicate that these differentiating agents activate different sets of genes, the melanogenic pathway being activated independently of gamma-glutamyltranspeptidase. The down regulation of B8G3 antigen by these agents may provide a common focus for understanding the essential action of differentiation inducers in melanoma cells.Keywords
This publication has 41 references indexed in Scilit:
- Stimulation of cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycleExperimental Cell Research, 1989
- Monoclonal Antibody Against a Melanosomal Protein in Melanotic and Amelanotic Human Melanoma CellsPigment Cell Research, 1989
- Cytoarchitecture of kirsten sarcoma virus‐transformed rat kidney fibroblasts: Butyrate‐induced reorganization within the actin microfilament networkJournal of Cellular Physiology, 1988
- Monoclonal Antibody Against Human Tyrosine and Reactive With Melanotic and Amelanotic Melanoma CellsJournal of Investigative Dermatology, 1988
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells.The Journal of cell biology, 1984
- Gamma-Glutamyl Transpeptidase in the Pigment Cells of Rhesus EyesJournal of Investigative Dermatology, 1981
- Enhancement of melanotic expression in cultured mouse smelanoma cells by retinoidsJournal of Cellular Physiology, 1981
- Effect of sodium butyrate on chromatin structureBiochemical and Biophysical Research Communications, 1980
- Human malignant melanoma cell linesPathology, 1979